Directory · IT
Biotechnology in Italy
A register of firms and the professionals working at them in the Biotechnology sector based in Italy. Browse the public index, then filter or export on Kipplo.
Companies
119 on file
Posy Pharmachem Pvt Ltd
Posy Pharmachem Pvt Ltd is a biotechnology company based out of Vico San Pancrazio, Genoa, Liguria, Italy.
11 to 50 staff
Andros Clinica Day Surgery Sezione Di Genetica Forense
A Palermo, ANDROS Medicina e Laboratori di Ricerca Clinica mette a vostra disposizione uno spazio dedicato esclusivamente alle indagini biologiche in ambito forense all’interno del quale lavorano operatori specializzati e di maturata esperienza in genetica forense. Il laboratorio è dotato delle più moderne tecnologie e, nel rispetto della catena di custodia, l’accesso allo stesso è limitato esclusivamente ai nostri esperti. Il training, l’accreditamento e la validazione dei processi sono essenziali per il laboratorio di Genetica Forense al fine di produrre risultati che siano accettati dalle autorità giudiziarie. Il personale del nostro laboratorio è in grado di dimostrare in qualunque momento l’accuratezza del proprio lavoro. La nostra sezione di genetica forense, infatti, partecipa a rigorosi controlli di qualità, sia a livello nazionale da parte della Società di Genetisti Forensi Italiani (Ge.F.i.), sia a livello internazionale da parte della International Society of Forensic Genetics – Spanish and Portuguese Speaking Working Group (ISFG-GHEP).
1 to 10 staff
Bio-Nk
La Bio-NK lavora per sviluppare il primo kit per la diagnosi precoce del Morbo di Parkinson.
1 to 10 staff
Biotechsol S.R.L
Biotechsol S.r.l. is an Italian company focused on biotechnologies. At the core of its activities, we find the biotech research, the development and production of new materials and applications, and the attention to the future possibilities of genetics and medical fields.
1 to 10 staff
Bonaka Italia - Cleaning Biotechnologies
Bonaka Italia è l’importatore e distributore esclusivo di PROM di Bonaka, azienda biotecnologica russa che da 10 anni studia, progetta e produce ceppi di batteri selezionati utilizzati nella pulizia di incrostazioni e depositi nelle apparecchiature degli impianti termici e tecnologici; i ceppi di batteri (PROM) vengono usati nei sistemi di riscaldamento e di raffreddamento, evaporatori, condensatori di turbine, reattori, scambiatori di calore etc. La nostra mission è aumentare l'efficienza delle attrezzature dedicate alla produzione e al consumo di calore, migliorando così le perfomance degli impianti e facendo diminuire i costi di esercizio, di produzione energetica e di manutenzione.
1 to 10 staff
Gibob
Gibob's core businesses are microorganism, fermentation technologies, services, products, equipment for several industries such as agriculture, food, feed beverage and others. Gibob has a valued expertise in engineering related to Submerged Fermentation (SmF), Solid State Fermentation (SSF) and the newly developed Dynamic Solid State Fermentation (DSSF), thin film evaporation, waste water sludge processing to agriculture conditioners, agriculture matrixes upgrading to fertilizers, products upgrading by microbial supplementation, etc. Gibob can supply: fermentors (SmF), DSSF Bioreactors, recovery and downstream processing and formulation equipment, thin film evaporators, several types of drying equipment, turn-key plants, revamping of obsolate plants and scale-up services.
1 to 10 staff
Justep - 2c S.R.L
Justep è un medical device creato per sostituire il bastone per i ciechi, dotato di intelligenza artificiale per dare il pieno supporto durante la navigazione e aiuta ad evitare tutti gli ostacoli e indica la miglior strada da percorrere per arrivare a destinazione, e non solo justep presenta diversi funzionalità che danno anche un supporto emotivo al paziente. Il nostro obiettivo è quello di rendere la navigazione per la persona non vedente un'esperienza unica e non più una fonte di paura e di insicurezza. Abbiamo sempre messo al centro della nostra tecnologia la persona non vedente perché vogliamo che i nostri pazienti escano di casa senza paura, vogliamo che i nostri pazienti abbiano una vita sociale migliore e soprattutto vogliamo che i nostri utenti abbiano meno incidenti nella strada.
1 to 10 staff
Neomatrix
NEOMATRIX is a individualised therapeutic cancer vaccine against tumour specific antigens, called neoantigens, arising from somatic gene mutations in malignant cells during neoplastic transformation. The tailored vaccine is intended for use as therapeutic vaccination in patients with locally advanced or metastatic solid tumours.
1 to 10 staff
Nexion Srl
field of activity: biotechnology, medical contact: paolo.galavotti@nexion.ws Paolo Galavotti is director of Nexion and has been working in the biomedical field since 1985. He has acquired technical and business experience in small and medium-sized companies and research centers, working on the design, development, and marketing of equipment for: manufacturing and testing disposable medical components and finished products for various applications (biomedical, biotech-pharma); electromedical machines for extracorporeal circulation to be used in intensive care; and machines and systems for the biotech-pharma sector. Nexion serves companies and research centers that work in the medical, biotech, and pharmaceutical sector, providing them with technical assistance in the research, design, development, and production of disposable products and medical devices, from the initial idea to the finished product. Nexion is located in Mirandola (Modena province), the largest biomedical cluster in Europe, which allows it to constantly monitor the technologies of the sector. Thanks to the knowledge and experience acquired in various fields of application (heart surgery, hemodialysis, hemofiltration, hemoconcentration, assisted fertilization, gynecology, infusion, obstetrics, transfusion, urology, and biotech-pharma), Nexion is able to work on specific projects.
1 to 10 staff
Procelltech
Relevant social, scientific and technological changes have led to new needs in health care and therapies. New technologies have allowed impressive results such as use of stem cells for innovative therapies and new methodologies for diagnosis and prognosis of chronic diseases. Areas of interest of Procelltech are Regenerative Medicine and Preclinical and Phase I-IV clinical trials Procelltech is a partner for public and private research institutes (University, Hospitals and Pharma Companies) that are going to build and manage a Cell Factory and/or a Biobanks in accordance to International Standard (Good Manufacturing Practice, cGMP, ICH) and Regulations (EC/1394/2007). To this aim, Procelltech offers GMP compliant Quality Control testing on biotech/cellular products for advanced therapies (e.g. cellular and gene therapy) according to European Pharmacopeia. Procelltech provides consultancy for designing a cGMP facility eg cGMP Cell Factory, for implementing Quality systems and for drafting and management of regulated documentation. Procelltech supports preclinical and clinical trials by developing research studies of biomarker (efficacy, potency and safety) through ex vivo and/or in vitro assays.
11 to 50 staff
Proxentia
ProXentia produces innovative analysis systems for safety and quality monitoring in the food supply chain. ProXentia’s device allows rapid analysis of raw materials entering and leaving the company. Because of its simplicity, the tests can be performed directly in the production or storage site, for more effective control and greater safety. The technology of ProXentia exploits light as a probing tool. The PRX device is indeed based on the proprietary RPI (Reflective Phantom Interface) technology, which exploits the light reflection of innovative materials and allows to perform rapid multiparametric diagnostic tests in a simple way with minimal intervention from the operator. A brand new light in the supply chain controls: simpler, safer and for everyone
1 to 10 staff
Xbiogem
XBIOGem è una società controllata dalla Fondazione Policlinico Universitario Agostino Gemelli IRCCS che propone linee di test genetici e di laboratorio al fine di rispondere alle esigenze diagnostiche emergenti. XBIOGem è specializzata nella fornitura di Test Genetici e di Laboratorio indirizzati a diversi ambiti: Oncologia, per lo screening di mutazioni genetiche e profilazioni molecolari; Microbiologia, riguardante le analisi del Microbiota Intestinale, Vaginale, dei relativi patogeni e l’analisi del Papilloma Virus; Medicina della Riproduzione, rivolta all’analisi genetica prenatale non invasiva e alla prevenzione dell’abortività precoce.
1 to 10 staff
Aequilibrium Pharma S.R.L
AEQ PHARMA is a Biotechnology Company developing and commercializing high quality mAbs. The Company is focused on creating a deep pipeline of clinically identical Biosimilars at significantly reduced prices for entry into both new and established markets. Our current pipeline consists of severals Biosimilars and several monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases. We develop, produce and release our APIs and Biosimilars in house with the latest available technology and to the highest quality standards for the supply of finished and ready to commercialize products worldwide.
1 to 10 staff
Inta Systems
Our mission is to develop and commercialize high-tech lab-on-a-chip for biomolecular analysis through the combination of nanotech and artificial intelligence. INTA is a spinoff from "Scuola Normale Superiore"(University of Pisa) and National Research Council of Italy.
1 to 10 staff
Strube Italia S.R.L
1 to 10 staff
Biocentis
Biocentis is a pioneering life-science company creating a new class of products: genetically engineered insects designed to control harmful species that threaten public health, agriculture, and biodiversity. Spun out of Imperial College London and backed by leading climate and deep-tech investors, we harness cutting-edge genome engineering and a proprietary technology platform to deliver highly effective, sustainable, and environmentally responsible insect control solutions. With teams in the UK and Italy, we bring together a diverse and accomplished group of experts who have built companies worth billions, pioneered CRISPR technologies, and delivered some of the world's most advanced insect control solutions. We are growing rapidly and always keen to connect with passionate people. If you’re excited about making a global impact at the intersection of science, technology, and sustainability — let’s talk- Biocentis has received investment under Italy's National Recovery and Resilience Plan (PNRR) and the European Union's Next Generation EU program.
11 to 50 staff
Biotecnologie Industriali Federico Ii
Cryolab Sol Group
CryoLab is a company focused on providing Biotechnology and Cryobiology services, formed in January 2012 by the Faculty of Medicine and Surgery of the "Tor Vergata" University in Rome. Since 2015 operates in partnership with the SOL Group SpA The SOL Group has a professional history of more than 90 years and is European leader in the design, construction, implementation and management of cryobiological rooms and biobanks certified as Medical Devices under the 93/42/CEE Directive, and in the production of medical gases used in the medical environment. At the centre of Cryolab's activities, authorized by the Italian Ministry of Health- storage services for biological samples- disaster recovery plans- IVF biological samples (gametes and embryos) transport- Stem cells and cord blood samples transport.
11 to 50 staff
Ixtal
1 to 10 staff
Orizor Scientific
Orizor Scientific è il nuovo brand specializzato nella distribuzione di strumentazione da laboratorio ad alta tecnologia, dispositivi diagnostici e per biotech.
1 to 10 staff
Alia Therapeutics
Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems expands the range of targetable genomic sites and increases the precision of genetic modifications, bringing gene editing to the next level of specificity and safety, which are required for therapeutic applications.
1 to 10 staff
Explora Biotech Srl
EXPLORA S.r.l. is a privately owned Italian company established in 2006 at the Technological Park “Tecnopolo Tiburtino” in Rome by a pool of young researchers and the support of a French seed capital organization INVENT SaS. EXPLORA is committed to the development of enabling technologies for biological engineering.
11 to 50 staff
Micoperi Blue Growth
Micoperi Blue Growth ricerca, produce e commercializza microalghe e prodotti derivati di altissima qualità. Attraverso le innovative tecnologie le microalghe, selezionate e coltivate interamente in Italia in filiera certificata e controllata, sono destinate a diversi settori fra cui alimentare, nutraceutico, cosmetico, farmaceutico, medico ed agricolo.
11 to 50 staff
Antifemo Srl - Winner Of America Innovation Prize 2023 & Iren Startup Award
NP-bioTech è una biotecnologia brevettata basata sull'impiego di un catalizzatore in grado di accelerare i processi fermentativi anche di biomasse scarsamente fermentescibili come pastazzo di agrumi, fanghi di depurazione, digestati anaerobici, senza ricorrere al alcun pretrattamento. Antifemo Srl è l'unico soggetto al mondo abilitato alla commercializzazione della tecnologia NP-bioTech, a cedere sub-licenze, a fornire impianti chiavi in mano, a valutare interventi di modifica di impianti esistenti e fornire supporto di processo after sale. Antifemo Srl, dal giugno 2021 riconosciuto lo status di start-up innovativa, è costantemente impegnata in progetti di ricerca scientifica, in collaborazione con centri di ricerca (CNR), università (Pisa, Sassari) e imprese del settore trattamento di rifiuti (Teate Ecologia SpA) e produttori di scarti organici (Red Island Srl) per migliorare l'efficacia della tecnologia, ampliare il campo applicativo e migliorare i prodotti biostabilizzati ottenuti, secondo un approccio di Circular Economy. NP-bioTech è in grado di fornire fertilizzanti organici a lento rilascio di macronutrienti e qualora nella matrice organica di partenza fossero presenti inquinanti organici (idrocarburi, BTEX) è in grado di degradarli efficacemente. Anche in presenza di microinquinanti persistenti (IPA, PCB, diossine e furani) NP-bioTech aggredisce efficacemente i centri funzionali di tale molecole riducendone la concentrazione anche di oltre il 90%.
1 to 10 staff